[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Diastolic Heart Failure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 71 pages | ID: 25767B2E94BEN
VPAResearch

US$ 1,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Diastolic Heart Failure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Diastolic Heart Failure. It presents in-depth analysis of Diastolic Heart Failure clinical trials across markets and companies. The research work is for providing complete understanding into trends in Diastolic Heart Failure.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Diastolic Heart Failure clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Diastolic Heart Failure

The research work is prepared through extensive and continuous research on Diastolic Heart Failure trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Diastolic Heart Failure patients are identified
  • The report includes panorama of Diastolic Heart Failure clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Diastolic Heart Failure clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Diastolic Heart Failure Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Diastolic Heart Failure Clinical Trials by Region
  2.2.2 Average Enrollment of Diastolic Heart Failure Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Diastolic Heart Failure Treatment, 2019

3. REGION WISE DIASTOLIC HEART FAILURE CLINICAL TRIALS

3.1 Asia Pacific Diastolic Heart Failure Clinical Trials by Country
3.2 Europe Diastolic Heart Failure Clinical Trials by Country
3.3 North America Diastolic Heart Failure Clinical Trials by Country
3.4 Middle East and Africa Diastolic Heart Failure Clinical Trials by Country
3.5 South and Central America Diastolic Heart Failure Clinical Trials by Country

4. DIASTOLIC HEART FAILURE CLINICAL TRIAL TRENDS

4.1 Start Year wise Diastolic Heart Failure Clinical Trials
4.2 Phase wise Diastolic Heart Failure Clinical Trials
4.3 Trial Status wise Diastolic Heart Failure Clinical Trials
4.4 Trial Type wise Diastolic Heart Failure Clinical Trials

5. DIASTOLIC HEART FAILURE AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Diastolic Heart Failure Trials by Year
5.2 Average Enrollment in Diastolic Heart Failure Trials by Phase
5.3 Average Enrollment in Diastolic Heart Failure Trials by Status
5.4 Average Enrollment in Diastolic Heart Failure Trials by Type of Trial

6. COMPANIES PARTICIPATING IN DIASTOLIC HEART FAILURE CLINICAL TRIALS

6.1 Diastolic Heart Failure Trials by Sponsor Type
6.2 Diastolic Heart Failure Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Diastolic Heart Failure Trials- Phase
7.2 Diastolic Heart Failure Trials- Phase
7.3 Diastolic Heart Failure Trials- Phase
7.4 Diastolic Heart Failure Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Diastolic Heart Failure Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Figure 5: Europe – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Figure 7: North America – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Figure 9: Diastolic Heart Failure Clinical Trials by Phase
Figure 10: Diastolic Heart Failure Clinical Trials by Trial Status
Figure 11: Diastolic Heart Failure Clinical Trials by Type
Figure 12: Diastolic Heart Failure Clinical Trials by Sponsor Type
Figure 13: Diastolic Heart Failure Clinical Trials by Leading Sponsors
Figure 14: Diastolic Heart Failure Average Enrollment by Phase
Figure 15: Diastolic Heart Failure Average Enrollment by Trial Status
Figure 16: Diastolic Heart Failure Average Enrollment by Type
Figure 17: Diastolic Heart Failure- Average Enrolment by Type of Sponsors
Figure 18: Diastolic Heart Failure- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Diastolic Heart Failure Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Table 5: Europe – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Table 7: North America – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Diastolic Heart Failure Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Diastolic Heart Failure Average Enrollment by Phase
Table 15: Diastolic Heart Failure Average Enrollment by Trial Status
Table 16: Diastolic Heart Failure Average Enrollment by Type
Table 17: Diastolic Heart Failure- Average Enrolment by Type of Sponsors
Table 18: Diastolic Heart Failure- Enrolment by Leading Sponsors


More Publications